$24.73
1.035[4.37%]
At close: Apr 26
$24.73
0[0.00%]
After Hours: 4:20PM EDT
Dyne Therapeutics
(NASDAQ:DYN)Latest News for Dyne Therapeutics Stock (NASDAQ:DYN)
Dyne Therapeutics Stock (NASDAQ: DYN)
Categories: All
Tuesday, March 26, 2024
Monday, March 25, 2024
- Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Mar 25, 2024, 2:44PM
- Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On MondayAvi Kapoor - Mar 25, 2024, 10:32AM
- Dyne Therapeutics shares are trading lower after the company announced a CEO transition.Benzinga Newsdesk - Mar 25, 2024, 8:35AM
- Dyne Therapeutics Has Appointed John Cox As President, Chief Executive Officer And A Member Of The Board Of Directors, Effective Immediately. He Succeeds Joshua Brumm, Who Has Chosen To Step DownBenzinga Newsdesk - Mar 25, 2024, 7:34AM
Thursday, March 14, 2024
Friday, March 08, 2024
Thursday, March 07, 2024
Wednesday, March 06, 2024
- HC Wainwright & Co. Reiterates Buy on Dyne Therapeutics, Maintains $36 Price TargetBenzinga Newsdesk - Mar 6, 2024, 12:59PM
- Piper Sandler Maintains Overweight Rating for Dyne Therapeutics: Here's What You Need To KnowBenzinga Insights - Mar 6, 2024, 12:00PM
- Stifel Maintains Buy on Dyne Therapeutics, Raises Price Target to $41Benzinga Newsdesk - Mar 6, 2024, 10:24AM
- Piper Sandler Maintains Overweight on Dyne Therapeutics, Raises Price Target to $29Benzinga Newsdesk - Mar 6, 2024, 9:27AM
Tuesday, March 05, 2024
- Oppenheimer Reiterates Outperform on Dyne Therapeutics, Raises Price Target to $47Benzinga Newsdesk - Mar 5, 2024, 7:52AM
- Recap: Dyne Therapeutics Q4 EarningsBenzinga Insights - Mar 5, 2024, 7:40AM
- Dyne Therapeutics Q4 EPS $(1.09) Misses $(0.92) Estimate, Cash Balance of $123.1MBenzinga Newsdesk - Mar 5, 2024, 7:36AM
Friday, March 01, 2024
Tuesday, February 20, 2024
Thursday, February 15, 2024
Friday, January 26, 2024
Monday, January 15, 2024
Friday, January 12, 2024
Friday, January 05, 2024
- Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Jan 5, 2024, 1:13PM
- Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market SessionAvi Kapoor - Jan 5, 2024, 6:19AM
- Dyne Therapeutics Prices $300M Public Offering Of 17.15M Common Stock At $17.50/ShareBenzinga Newsdesk - Jan 5, 2024, 1:31AM
Thursday, January 04, 2024
- Dyne Therapeutics shares are trading higher after Raymond James maintained a Strong Buy on the stock and raised its price target from $27 to $56.Benzinga Newsdesk - Jan 4, 2024, 3:39PM
- Crude Oil Moves Lower; Walgreens Posts Upbeat EarningsAvi Kapoor - Jan 4, 2024, 2:15PM
- Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Jan 4, 2024, 1:37PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Jan 4, 2024, 12:31PM
- Dow Surges 200 Points; US Services PMI Edges Higher In DecemberAvi Kapoor - Jan 4, 2024, 12:00PM
- Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On ThursdayAvi Kapoor - Jan 4, 2024, 10:12AM
- Cal-Maine Posts Downbeat Q2 Results, Joins Dyne Therapeutics, OPKO Health And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionAvi Kapoor - Jan 4, 2024, 5:46AM
- Raymond James Maintains Strong Buy on Dyne Therapeutics, Raises Price Target to $56Benzinga Newsdesk - Jan 4, 2024, 4:30AM
Wednesday, January 03, 2024
- Dyne Therapeutics Announces Underwritten Public Offering Of $175M Of Common StockBenzinga Newsdesk - Jan 3, 2024, 4:26PM
- Dyne Therapeutics shares are trading higher after the company announced initial clinical data from its ACHIEVE trial of DYNE-101 in patients with DM1 and its DELIVER trial of DYNE-251 in patients with DMD.Benzinga Newsdesk - Jan 3, 2024, 1:12PM
- Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionAvi Kapoor - Jan 3, 2024, 12:58PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Jan 3, 2024, 12:31PM
- TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On WednesdayAvi Kapoor - Jan 3, 2024, 10:24AM
- Why Is Rare Muscle Disease-Focused Dyne Therapeutics Stock Soaring Today?Vandana Singh - Jan 3, 2024, 8:07AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Jan 3, 2024, 8:05AM
- Dyne Therapeutics Announces Initial Clinical Data From Its ACHIEVE Trial Of DYNE-101 In Patients With Myotonic Dystrophy Type 1 And DELIVER Trial Of DYNE-251 In Patients With Duchenne Muscular Dystrophy Who Are Amenable To Exon 51Benzinga Newsdesk - Jan 3, 2024, 6:33AM
Friday, November 03, 2023
Monday, October 30, 2023
- Dyne Therapeutics shares are trading higher after the company reported Q3 financial results.Benzinga Newsdesk - Oct 30, 2023, 1:36PM
- Dyne Therapeutics' Cash, Cash Equivalents And Marketable Securities Of $157.8M, Expected To Provide Cash Runway Through 2024Benzinga Newsdesk - Oct 30, 2023, 7:32AM
- Dyne Therapeutics Q3 EPS $(0.99) Misses $(0.83) EstimateBenzinga Newsdesk - Oct 30, 2023, 7:30AM